Open access
Open access
Powered by Google Translator Translator

Rheumatology

M-A | Metabolic adverse events associated with systemic corticosteroid therapy

24 Jan, 2023 | 14:10h | UTC

Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis – BMJ Open

 

Health and economic outcomes associated with musculoskeletal disorders attributable to high BMI in 192 countries

23 Jan, 2023 | 13:16h | UTC

Health and Economic Outcomes Associated With Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019 – JAMA Network Open

 

RCT | Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to TNFα inhibitors

19 Jan, 2023 | 14:05h | UTC

Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE) – The Lancet

Related Study: Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL) – The Lancet

 

Cohort Study | Hydroxychloroquine dose and risk for incident retinopathy

18 Jan, 2023 | 14:21h | UTC

Hydroxychloroquine Dose and Risk for Incident Retinopathy: A Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: Long-term low-dose hydroxychloroquine use associated with low risk for retinopathy – American College of Physicians

Commentary: Long-term low-dose hydroxychloroquine use associated with low risk for retinopathy – ACP Internist

 

RCT | Efficacy and safety of Risankizumab for active psoriatic arthritis

18 Jan, 2023 | 14:04h | UTC

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study – Rheumatology

Commentary: Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis – HealthDay

 

Phase 2 RCT | No benefit from the Bruton’s tyrosine kinase inhibitor Evobrutinib in systemic lupus erythematosus

12 Jan, 2023 | 12:54h | UTC

Efficacy and Safety of the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Trial – ACR Open Rheumatology

 

Atypical ulcers: a stepwise approach for clinicians

10 Jan, 2023 | 14:00h | UTC

Atypical Ulcers: A Stepwise Approach for Clinicians – Wounds

 

ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults

9 Jan, 2023 | 14:59h | UTC

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

See also: Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians – Annals of Internal Medicine

News Release: American College of Physicians recommends bisphosphonates for initial treatment for osteoporosis in males and postmenopausal females diagnosed with primary osteoporosis

Summary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults

 

2022 ACR/EULAR classification criteria for giant cell arteritis.

16 Dec, 2022 | 13:39h | UTC

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis – Annals of the Rheumatic Diseases

News Release: Updated: GCA Classification Criteria – European Alliance of Associations for Rheumatology

 

RCT | Effect of diet and exercise on knee pain in patients with osteoarthritis and overweight or obesity.

16 Dec, 2022 | 13:36h | UTC

Effect of Diet and Exercise on Knee Pain in Patients With Osteoarthritis and Overweight or Obesity: A Randomized Clinical Trial – JAMA (free for a limited period)

See also: Visual Abstract

 

Pictorial Review | Nerve entrapment syndromes of the upper limb.

15 Dec, 2022 | 13:25h | UTC

Nerve entrapment syndromes of the upper limb: a pictorial review – Insights into Imaging

 

SR | Use of acupuncture for adult health conditions, 2013 to 2021.

14 Dec, 2022 | 14:54h | UTC

Use of Acupuncture for Adult Health Conditions, 2013 to 2021: A Systematic Review – JAMA Network Open

 

2022 ACR/EULAR classification criteria for Takayasu arteritis.

12 Dec, 2022 | 12:50h | UTC

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis – Annals of the Rheumatic Diseases

News Release: Classification criteria established for Takayasu arteritis – European Alliance of Associations for Rheumatology, EULAR

 

Cohort Study | Cutaneous involvement in catastrophic antiphospholipid syndrome.

8 Dec, 2022 | 12:53h | UTC

Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients – JAMA Dermatology (free for a limited period)

 

Commentary on Twitter

 

RCT | Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment.

7 Dec, 2022 | 14:29h | UTC

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL) – The Lancet

 

Brief Review | Management of pericarditis in rheumatic diseases.

7 Dec, 2022 | 14:16h | UTC

Management of Pericarditis in Rheumatic Diseases – American College of Cardiology

 

Case Report | Vitamin D intoxication and severe hypercalcemia complicating nutritional supplements misuse.

6 Dec, 2022 | 13:56h | UTC

Vitamin D intoxication and severe hypercalcaemia complicating nutritional supplements misuse – BMJ Case Reports

Commentaries:

Vitamin D supplement ‘overdosing’ is possible and harmful, warn doctors – Medical Dialogues

How an increasingly popular supplement landed a man in the hospital – CNN

You Can Take Too Much Vitamin D — One Man Found Out the Hard Way – HealthDay

 

Guideline | Lateral elbow pain and muscle function impairments.

5 Dec, 2022 | 00:15h | UTC

Lateral Elbow Pain and Muscle Function Impairments – Journal of Orthopaedic & Sports Physical Therapy

 

M-A | Thiazide diuretics and fracture risk.

29 Nov, 2022 | 14:23h | UTC

Thiazide Diuretics and Fracture Risk: A Systematic Review and Meta-Analysis of Randomized Clinical Trials – JBMR Plus

 

Podcast | Back pain update.

29 Nov, 2022 | 14:07h | UTC

#368 Back Pain Update with
Dr. Austin Baraki – The Curbsiders

 

RCT | Remotely delivered cognitive behavioral and personalized exercise interventions for fatigue severity and impact in rheumatic diseases.

29 Nov, 2022 | 13:46h | UTC

Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial – The Lancet Rheumatology

 

SR | Yoga for chronic non‐specific low back pain.

27 Nov, 2022 | 22:08h | UTC

Yoga for chronic non‐specific low back pain – Cochrane Library

Summary: Yoga for chronic non-specific low back pain – Cochrane Library

Commentaries: 

Yoga may have health benefits for people with chronic non-specific lower back pain – Cochrane Library

Is yoga good for back pain? Here’s the evidence – Evidently Cochrane

 

RCT | Vitamin D fails to prevent statin-associated muscle symptoms among new statin users.

25 Nov, 2022 | 12:40h | UTC

Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo – JAMA Cardiology (free for a limited period)

Commentary: Vitamin D fails to reduce statin-associated muscle pain – Northwestern University

 

Commentary on Twitter

 

RT | Routine early arthroscopic partial meniscectomy is not superior to physical therapy for traumatic meniscal tears.

25 Nov, 2022 | 12:38h | UTC

Arthroscopic partial meniscectomy versus physical therapy for traumatic meniscal tears in a young study population: a randomised controlled trial – British Journal of Sports Medicine

Commentary: Arthroscopic Partial Meniscectomy vs Physical Therapy for Traumatic Meniscal Tears in a Young Study Population: what does a recent RCT show? – BJSM Blog

 

Commentary on Twitter

 

SR | Strategies to prevent and manage running-related knee injuries.

25 Nov, 2022 | 12:37h | UTC

Strategies to prevent and manage running-related knee injuries: a systematic review of randomised controlled trials – British Journal of Sports Medicine (link to abstract – $ for full-text)

Commentaries:

How can we prevent and manage running-related knee injuries? – BJSM Blog

Changes in technique, footwear and intervention prevent running-related knee injuries – Physician’s weekly

 

Commentary from the author on Twitter

 

Stay Updated in Your Specialty

No spam, just news.